BRIEF-Organon Appoints Company Executive Joseph Morrissey As Interim CEO And Board Chair Carrie Cox As Executive Chair Announces Results Of Audit Committee Investigation

Reuters

Oct 27, 2025

BRIEF-Organon Appoints Company Executive Joseph Morrissey As Interim CEO And Board Chair Carrie Cox As Executive Chair Announces Results Of Audit Committee Investigation

Organon & Co OGN.N:

ORGANON APPOINTS COMPANY EXECUTIVE JOSEPH MORRISSEY AS INTERIM CEO AND BOARD CHAIR CARRIE COX AS EXECUTIVE CHAIR; ANNOUNCES RESULTS OF AUDIT COMMITTEE INVESTIGATION
ORGANON & CO - APPOINTS JOSEPH MORRISSEY AS INTERIM CEO
ORGANON & CO - KEVIN ALI RESIGNS AS CEO AND BOARD MEMBER
ORGANON: INVESTIGATION FOUND THAT SOME WHOLESALERS IN US WERE ASKED TO BUY MORE NEXPLANON THAN NEEDED AT END OF Q4 2022, Q3 & Q4 2024, Q1, Q2, Q3 2025
ORGANON: INVESTIGATION FOUND NEXPLANON SALES REPRESENTED LESS THAN 1% OF CO'S CONSOLIDATED REVENUE FOR YEAR ENDED DEC 31, 2022 OR DEC 31, 2024
ORGANON & CO: FINDINGS TO DATE DO NOT NECESSITATE A RESTATEMENT OR REVISION TO ANY PREVIOUSLY ISSUED FINANCIAL STATEMENTS
ORGANON & CO: TAKING REMEDIAL ACTIONS TO IMPROVE ITS FINANCIAL CONTROLS AND ADDRESS ANY MATERIAL WEAKNESSES
ORGANON & CO: IN CONNECTION WITH INVESTIGATION, TERMINATED EMPLOYMENT OF HEAD OF U.S. COMMERCIAL & GOVERNMENT AFFAIRS
ORGANON & CO: THERE HAS BEEN NO FINDING THAT CFO WAS AWARE OF IMPROPER WHOLESALER SALES PRACTICES
ORGANON & CO: INITIATING A SEARCH FOR A PERMANENT CEO, INCLUDING BOTH INTERNAL AND EXTERNAL CANDIDATES
ORGANON & CO: IMPROPER NEXPLANON SALES PRACTICES ENABLED CO TO MEET GUIDANCE AND/OR CERTAIN EXTERNAL REVENUE EXPECTATIONS

Source text: ID:nBw6cK19Ha

Further company coverage: OGN.N

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2578641401"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2578641401\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2578641401?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-27 21:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2578641401","market":"fut","top_or_hot":-1,"title":"BRIEF-Organon Appoints Company Executive Joseph Morrissey As Interim CEO And Board Chair Carrie Cox As Executive Chair Announces Results Of Audit Committee Investigation","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Organon Appoints Company Executive Joseph Morrissey As Interim CEO And Board Chair Carrie Cox As Executive Chair Announces Results Of Audit Committee Investigation</title></head><body><p>Organon &amp; Co <span>OGN.N</span>:</p><ul><li><p>ORGANON APPOINTS COMPANY EXECUTIVE JOSEPH MORRISSEY AS INTERIM CEO AND BOARD CHAIR CARRIE COX AS EXECUTIVE CHAIR; ANNOUNCES RESULTS OF AUDIT COMMITTEE INVESTIGATION</p></li><li><p>ORGANON &amp; CO - APPOINTS JOSEPH MORRISSEY AS INTERIM CEO</p></li><li><p>ORGANON &amp; CO - KEVIN ALI RESIGNS AS CEO AND BOARD MEMBER</p></li><li><p>ORGANON: INVESTIGATION FOUND THAT SOME WHOLESALERS IN US WERE ASKED TO BUY MORE NEXPLANON THAN NEEDED AT END OF Q4 2022, Q3 &amp; Q4 2024, Q1, <a href=\"https://laohu8.com/S/QTWO\">Q2</a>, Q3 2025</p></li><li><p>ORGANON: INVESTIGATION FOUND NEXPLANON SALES REPRESENTED LESS THAN 1% OF CO'S CONSOLIDATED REVENUE FOR YEAR ENDED DEC 31, 2022 OR DEC 31, 2024</p></li><li><p>ORGANON &amp; CO: FINDINGS TO DATE DO NOT NECESSITATE A RESTATEMENT OR REVISION TO ANY PREVIOUSLY ISSUED FINANCIAL STATEMENTS</p></li><li><p>ORGANON &amp; CO: TAKING REMEDIAL ACTIONS TO IMPROVE ITS FINANCIAL CONTROLS AND ADDRESS ANY MATERIAL WEAKNESSES</p></li><li><p>ORGANON &amp; CO: IN CONNECTION WITH INVESTIGATION, TERMINATED EMPLOYMENT OF HEAD OF U.S. COMMERCIAL &amp; GOVERNMENT AFFAIRS</p></li><li><p>ORGANON &amp; CO: THERE HAS BEEN NO FINDING THAT CFO WAS AWARE OF IMPROPER WHOLESALER SALES PRACTICES</p></li><li><p>ORGANON &amp; CO: INITIATING A SEARCH FOR A PERMANENT CEO, INCLUDING BOTH INTERNAL AND EXTERNAL CANDIDATES</p></li><li><p>ORGANON &amp; CO:  IMPROPER NEXPLANON SALES PRACTICES ENABLED CO TO MEET GUIDANCE AND/OR CERTAIN EXTERNAL REVENUE EXPECTATIONS</p></li></ul><p>Source text: <span>ID:nBw6cK19Ha</span></p><p>Further company coverage: <span>OGN.N</span></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Organon Appoints Company Executive Joseph Morrissey As Interim CEO And Board Chair Carrie Cox As Executive Chair Announces Results Of Audit Committee Investigation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Organon Appoints Company Executive Joseph Morrissey As Interim CEO And Board Chair Carrie Cox As Executive Chair Announces Results Of Audit Committee Investigation\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-10-27 21:15</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Organon Appoints Company Executive Joseph Morrissey As Interim CEO And Board Chair Carrie Cox As Executive Chair Announces Results Of Audit Committee Investigation</title></head><body><p>Organon &amp; Co <span>OGN.N</span>:</p><ul><li><p>ORGANON APPOINTS COMPANY EXECUTIVE JOSEPH MORRISSEY AS INTERIM CEO AND BOARD CHAIR CARRIE COX AS EXECUTIVE CHAIR; ANNOUNCES RESULTS OF AUDIT COMMITTEE INVESTIGATION</p></li><li><p>ORGANON &amp; CO - APPOINTS JOSEPH MORRISSEY AS INTERIM CEO</p></li><li><p>ORGANON &amp; CO - KEVIN ALI RESIGNS AS CEO AND BOARD MEMBER</p></li><li><p>ORGANON: INVESTIGATION FOUND THAT SOME WHOLESALERS IN US WERE ASKED TO BUY MORE NEXPLANON THAN NEEDED AT END OF Q4 2022, Q3 &amp; Q4 2024, Q1, <a href=\"https://laohu8.com/S/QTWO\">Q2</a>, Q3 2025</p></li><li><p>ORGANON: INVESTIGATION FOUND NEXPLANON SALES REPRESENTED LESS THAN 1% OF CO'S CONSOLIDATED REVENUE FOR YEAR ENDED DEC 31, 2022 OR DEC 31, 2024</p></li><li><p>ORGANON &amp; CO: FINDINGS TO DATE DO NOT NECESSITATE A RESTATEMENT OR REVISION TO ANY PREVIOUSLY ISSUED FINANCIAL STATEMENTS</p></li><li><p>ORGANON &amp; CO: TAKING REMEDIAL ACTIONS TO IMPROVE ITS FINANCIAL CONTROLS AND ADDRESS ANY MATERIAL WEAKNESSES</p></li><li><p>ORGANON &amp; CO: IN CONNECTION WITH INVESTIGATION, TERMINATED EMPLOYMENT OF HEAD OF U.S. COMMERCIAL &amp; GOVERNMENT AFFAIRS</p></li><li><p>ORGANON &amp; CO: THERE HAS BEEN NO FINDING THAT CFO WAS AWARE OF IMPROPER WHOLESALER SALES PRACTICES</p></li><li><p>ORGANON &amp; CO: INITIATING A SEARCH FOR A PERMANENT CEO, INCLUDING BOTH INTERNAL AND EXTERNAL CANDIDATES</p></li><li><p>ORGANON &amp; CO:  IMPROPER NEXPLANON SALES PRACTICES ENABLED CO TO MEET GUIDANCE AND/OR CERTAIN EXTERNAL REVENUE EXPECTATIONS</p></li></ul><p>Source text: <span>ID:nBw6cK19Ha</span></p><p>Further company coverage: <span>OGN.N</span></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2065170008.USD","symbol_name":"M&G (LUX) GLOBAL MAXIMA \"A\" (USD) INC","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251027:nTUAC3JM4K:1","article_id":"2578641401","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2578641401","pubTimestamp":1761570906,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Organon Appoints Company Executive Joseph Morrissey As Interim CEO And Board Chair Carrie Cox As Executive Chair Announces Results Of Audit Committee InvestigationOrganon & Co OGN.N:ORGANON APPO","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2065170008.USD":"M&G (LUX) GLOBAL MAXIMA \"A\" (USD) INC","OGN":"Organon & Co","LU2065171311.SGD":"M&G (LUX) GLOBAL MAXIMA \"A\" (SGD) ACC","BK4559":"巴菲特持仓","LU2065169927.USD":"M&G (LUX) GLOBAL MAXIMA \"A\" (USD) ACC","BK4007":"制药","LU2065171402.SGD":"M&G (LUX) GLOBAL MAXIMA \"A\" (SGD) INC","BK4588":"碎股","BK4585":"ETF&股票定投概念"},"translate_title":"简报-Organon任命公司高管Joseph Morrissey为临时首席执行官，董事会主席Carrie Cox为执行主席宣布审计委员会调查结果","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OGN":0.9},"content_text":"BRIEF-Organon Appoints Company Executive Joseph Morrissey As Interim CEO And Board Chair Carrie Cox As Executive Chair Announces Results Of Audit Committee InvestigationOrganon & Co OGN.N:ORGANON APPOINTS COMPANY EXECUTIVE JOSEPH MORRISSEY AS INTERIM CEO AND BOARD CHAIR CARRIE COX AS EXECUTIVE CHAIR; ANNOUNCES RESULTS OF AUDIT COMMITTEE INVESTIGATIONORGANON & CO - APPOINTS JOSEPH MORRISSEY AS INTERIM CEOORGANON & CO - KEVIN ALI RESIGNS AS CEO AND BOARD MEMBERORGANON: INVESTIGATION FOUND THAT SOME WHOLESALERS IN US WERE ASKED TO BUY MORE NEXPLANON THAN NEEDED AT END OF Q4 2022, Q3 & Q4 2024, Q1, Q2, Q3 2025ORGANON: INVESTIGATION FOUND NEXPLANON SALES REPRESENTED LESS THAN 1% OF CO'S CONSOLIDATED REVENUE FOR YEAR ENDED DEC 31, 2022 OR DEC 31, 2024ORGANON & CO: FINDINGS TO DATE DO NOT NECESSITATE A RESTATEMENT OR REVISION TO ANY PREVIOUSLY ISSUED FINANCIAL STATEMENTSORGANON & CO: TAKING REMEDIAL ACTIONS TO IMPROVE ITS FINANCIAL CONTROLS AND ADDRESS ANY MATERIAL WEAKNESSESORGANON & CO: IN CONNECTION WITH INVESTIGATION, TERMINATED EMPLOYMENT OF HEAD OF U.S. COMMERCIAL & GOVERNMENT AFFAIRSORGANON & CO: THERE HAS BEEN NO FINDING THAT CFO WAS AWARE OF IMPROPER WHOLESALER SALES PRACTICESORGANON & CO: INITIATING A SEARCH FOR A PERMANENT CEO, INCLUDING BOTH INTERNAL AND EXTERNAL CANDIDATESORGANON & CO:  IMPROPER NEXPLANON SALES PRACTICES ENABLED CO TO MEET GUIDANCE AND/OR CERTAIN EXTERNAL REVENUE EXPECTATIONSSource text: ID:nBw6cK19HaFurther company coverage: OGN.N","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"executive,event","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}